Abstract
A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Current Pharmaceutical Analysis
Title: Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Volume: 4 Issue: 3
Author(s): Bo Yang, Yong Chen, Jun Lin and Yu Liu
Affiliation:
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Abstract: A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Export Options
About this article
Cite this article as:
Yang Bo, Chen Yong, Lin Jun and Liu Yu, Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives, Current Pharmaceutical Analysis 2008; 4 (3) . https://dx.doi.org/10.2174/157341208785161272
DOI https://dx.doi.org/10.2174/157341208785161272 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member:
Current Organic Chemistry Vaccine Therapy Update for Pregnant, Immunocompromised, and Chronic Diseases Patients
Recent Patents on Inflammation & Allergy Drug Discovery Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Current Status of Computer-Aided Drug Design for Type 2 Diabetes
Current Computer-Aided Drug Design Design and In Vitro Evaluation of Five Inhibitors of Mycobacterium Tuberculosis
Letters in Drug Design & Discovery Anti-Tuberculosis Activity of α-Helical Antimicrobial Peptides: De Novo Designed L- and D-Enantiomers Versus L- and D-LL37
Protein & Peptide Letters Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics
Current Drug Targets - Infectious Disorders Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents
Current Topics in Medicinal Chemistry The Ever Changing Face of Antibiotic Resistance: Prevailing Problems and Preventive Measures
Current Drug Metabolism Solubility and Permeability Measurement and Applications in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Toll-Like Receptors in Skin Infections and Inflammatory Diseases
Infectious Disorders - Drug Targets Synthesis and Biological Activity of 3-(substitutedphenyl)- 6-(4-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies
Current Pharmaceutical Design Meet Our Editor:
Current Enzyme Inhibition A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry New Potential Pharmaceutical Applications of Hypericum Species
Mini-Reviews in Medicinal Chemistry Nanocarriers Made from Non-Ionic Surfactants or Natural Polymers for Pulmonary Drug Delivery
Current Pharmaceutical Design Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)
Current Pharmacogenomics and Personalized Medicine Advances of Bioinformatics Applied to Development and Evaluation of Boron-Containing Compounds
Current Organic Chemistry Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry